Deutsch English Français

Contact

EP0194276

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...

News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...

Extract from the Register of European Patents

EP About this file: EP0194276

EP0194276 - PRODUCTION OF CHIMERIC ANTIBODIES [Right-click to bookmark this link]
Status	Patent maintained as amended Status updated on 30.11.2001 Database last updated on 23.04.2024
Most recent event Tooltip	19.09.2008	Change - opposition data/opponents data or that of the opponents representative	published on 22.10.2008 [2008/43]
Applicant(s)	For all designated states CELLTECH THERAPEUTICS LIMITED 208 Bath Road Slough Berkshire SL1 3WE / GB
	[N/P]
Former [2002/03]	For all designated states CELLTECH THERAPEUTICS LIMITED 208 Bath Road Slough, Berkshire SL1 3WE / GB
Former [1997/39]	For all designated states CELLTECH THERAPEUTICS LIMITED 216 Bath Road Slough, Berkshire SL1 4EN / GB
Former [1986/38]	For all designated states CELLTECH LIMITED 244-250 Bath Road Slough Berkshire SL1 4DY / GB
Inventor(s)	01 / NEUBERGER, Michael, Samuel 34 Bateman Street Cambridge CB2 1MA / GB
	02 / RABBITTS, Terence, Howard Woodside, High Street Hildersham Cambridge CB1 6BU / GB
	[1986/38]
Representative(s)	Mercer, Christopher Paul, et al Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB
	[N/P]
Former [2001/17]	Mercer, Christopher Paul, et al Carpmaels & Ransford 43, Bloomsbury Square London WC1A 2RA / GB
Former [1986/38]	Votier, Sidney David, et al CARPMAELS & RANSFORD 43, Bloomsbury Square London WC1A 2RA / GB
Application number, filing date	85904274.9	03.09.1985
	[1986/38]
	WO1985GB00392
Priority number, date	GB19840022238	03.09.1984 Original published format: GB 8422238
	[1986/38]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO8601533
	Date:	13.03.1986
	Language:	EN
	[1986/06]
	Type:	A1 Application with search report
	No.:	EP0194276
	Date:	17.09.1986
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 13.03.1986 takes the place of the publication of the European patent application.
	[1986/38]
	Type:	B1 Patent specification
	No.:	EP0194276
	Date:	11.08.1993
	Language:	EN
	[1993/32]
	Type:	B2 New European patent specification
	No.:	EP0194276
	Date:	16.01.2002
	Language:	EN
	[2002/03]
Search report(s)	International search report - published on:	EP	13.03.1986
Classification	IPC:	C12N15/13, C12N15/62, A61K39/395, C12P21/00, G01N33/563	[1993/32]
	CPC:	C07K16/44 (EP); C07K16/462 (EP); G01N33/531 (EP); G01N33/563 (EP); C07K2317/24 (EP); C07K2319/00 (EP); (+) C07K2319/30 (EP) (-)
	Former IPC [1986/38]	C12N15/00, C07K15/00, A61K39/395, C07K3/18, C12N5/00, C12P21/00, G01N33/563
Designated contracting states	AT, BE, CH, DE, FR, GB, IT, LI, LU, NL, SE [1986/38]
Title	German:	HERSTELLUNG VON CHIMÄREN ANTIKÖRPERN	[1993/32]
	English:	PRODUCTION OF CHIMERIC ANTIBODIES	[1986/38]
	French:	PRODUCTION D'ANTICORPS CHIMERIQUES	[1986/38]
	Former [1986/38]	HERSTELLUNG VON SCHIMÄRISCHEN ANTIKÖRPERN
Entry into regional phase	18.04.1986	National basic fee paid
	18.04.1986	Designation fee(s) paid
	18.04.1986	Examination fee paid
Examination procedure	18.04.1986	Examination requested [1986/38]
	20.05.1988	Despatch of a communication from the examining division (Time limit: M07)
	29.12.1988	Reply to a communication from the examining division
	12.07.1989	Despatch of a communication from the examining division (Time limit: M04)
	17.11.1989	Reply to a communication from the examining division
	10.05.1990	Despatch of a communication from the examining division (Time limit: M06)
	13.11.1990	Reply to a communication from the examining division
	19.02.1991	Despatch of a communication from the examining division (Time limit: M04)
	19.06.1991	Reply to a communication from the examining division
	14.10.1991	Despatch of a communication from the examining division (Time limit: M04)
	14.02.1992	Reply to a communication from the examining division
	25.03.1992	Despatch of communication of intention to grant (Approval: Yes)
	26.11.1992	Despatch of communication that the application is refused, reason: formalities examination {1}
	17.02.1993	Communication of intention to grant the patent
	13.04.1993	Fee for grant paid
	13.04.1993	Fee for publishing/printing paid
Opposition(s)	Opponent(s)	01 11.05.1994 26.05.1994 ADMISSIBLE Xoma Corp. 2910 Seventh St. Berkeley, California 94710 / US Opponent's representative Vossius & Partner Patentanwälte Rechtsanwälte mbB Siebertstrasse 3 81675 München / DE
		02 11.05.1994 27.07.1994 ADMISSIBLE Aventis Pharma Deutschland GmbH 65926 Frankfurt am Main / DE Opponent's representative Müller-Gerger, Thomas Aventis Pharma Deutschland GmbH Patent- und Lizenzabteilung 65926 Frankfurt am Main / DE
		03 11.05.1994 24.06.1994 ADMISSIBLE Roche Diagnostics GmbH Sandhoferstr. 116 68305 Mannheim / DE Opponent's representative Schreiner, Siegfried, et al, et al Roche Diagnostics GmbH Patent Department (TR-E) Nonnenwald 2 82377 Penzberg / DE
		[N/P]
	Former [2008/43]
	Opponent(s)	01 11.05.1994 26.05.1994 ADMISSIBLE Xoma Corp. 2910 Seventh St. Berkeley, California 94710 / US Opponent's representative Vossius & Partner Postfach 86 07 67 81634 München / DE
		02 11.05.1994 27.07.1994 ADMISSIBLE Aventis Pharma Deutschland GmbH 65926 Frankfurt am Main / DE Opponent's representative Müller-Gerger, Thomas, Dr. Aventis Pharma Deutschland GmbH, Patent- und Lizenzabteilung 65926 Frankfurt am Main / DE
		03 11.05.1994 24.06.1994 ADMISSIBLE Roche Diagnostics GmbH Sandhoferstr. 116 68305 Mannheim / DE Opponent's representative Schreiner, Siegfried, et al, et al Roche Diagnostics GmbH Patent Department (TR-E) Nonnenwald 2 82377 Penzberg / DE
	Former [2008/35]
	Opponent(s)	01 11.05.1994 26.05.1994 ADMISSIBLE Xoma Corp. 2910 Seventh St. Berkeley, California 94710 / US Opponent's representative Vossius & Partner Postfach 86 07 67 81634 München / DE
		02 11.05.1994 27.07.1994 ADMISSIBLE Aventis Pharma Deutschland GmbH 65926 Frankfurt am Main / DE Opponent's representative Müller-Gerger, Thomas, Dr. Aventis Pharma Deutschland GmbH, Patent- und Lizenzabteilung 65926 Frankfurt am Main / DE
		03 11.05.1994 24.06.1994 ADMISSIBLE Roche Diagnostics GmbH Sandhoferstr. 116 68305 Mannheim / DE Opponent's representative Schreiner, Siegfried, et al, et al Roche Diagnostics GmbH, Werk Penzberg, Abt. GE-TB, Postfach 11 52 82372 Penzberg / DE
	Former [2001/24]
	Opponent(s)	01 11.05.1994 26.05.1994 ADMISSIBLE Xoma Corp. 2910 Seventh St. Berkeley, California 94710 / US Opponent's representative VOSSIUS & PARTNER P.O. Box 86 07 67 D-81634 München / DE
		02 11.05.1994 27.07.1994 ADMISSIBLE Aventis Pharma Deutschland GmbH 65926 Frankfurt am Main / DE Opponent's representative Müller-Gerger, Thomas, Dr. Aventis Pharma Deutschland GmbH, Patent- und Lizenzabteilung 65926 Frankfurt am Main / DE
		03 11.05.1994 24.06.1994 ADMISSIBLE Roche Diagnostics GmbH Sandhoferstr. 116 68305 Mannheim / DE Opponent's representative Schreiner, Siegfried, et al, et al Roche Diagnostics GmbH, Werk Penzberg, Abt. GE-TB, Postfach 11 52 82372 Penzberg / DE
	Former [1999/37]
	Opponent(s)	01 11.05.1994 26.05.1994 ADMISSIBLE Xoma Corp. 2910 Seventh St. Berkeley, California 94710 / US Opponent's representative VOSSIUS & PARTNER P.O. Box 86 07 67 D-81634 München / DE
		02 11.05.1994 27.07.1994 ADMISSIBLE HOECHST AKTIENGESELLSCHAFT 65926 Frankfurt am Main / DE Opponent's representative Müller-Gerger, Thomas, Dr. Hoechst Marion Roussel Deutschland GmbH Patent- und Lizenzabteilung Gebäude K 801 65926 Frankfurt am Main / DE
		03 11.05.1994 24.06.1994 ADMISSIBLE Roche Diagnostics GmbH Sandhoferstr. 116 68305 Mannheim / DE Opponent's representative Schreiner, Siegfried, et al, et al Roche Diagnostics GmbH, Werk Penzberg, Abt. GE-TB, Postfach 11 52 82372 Penzberg / DE
	Former [1999/15]
	Opponent(s)	01 11.05.1994 26.05.1994 ADMISSIBLE Xoma Corp. 2910 Seventh St. Berkeley, California 94710 / US Opponent's representative VOSSIUS & PARTNER P.O. Box 86 07 67 D-81634 München / DE
		02 11.05.1994 27.07.1994 ADMISSIBLE Behringwerke Aktiengesellschaft Emil-von-Behring-Strasse 76 35041 Marburg / DE Opponent's representative Lauppe, Hans Friedrich (DE) Behringwerke AG Postfach 11 40 D-35001 Marburg / DE
		03 11.05.1994 24.06.1994 ADMISSIBLE Roche Diagnostics GmbH Sandhoferstr. 116 68305 Mannheim / DE Opponent's representative Schreiner, Siegfried, et al, et al Roche Diagnostics GmbH, Werk Penzberg, Abt. GE-TB, Postfach 11 52 82372 Penzberg / DE
	Former [1995/27]
	Opponent(s)	01 11.05.1994 26.05.1994 ADMISSIBLE Xoma Corp. 2910 Seventh St. Berkeley, California 94710 / US Opponent's representative VOSSIUS & PARTNER P.O. Box 86 07 67 D-81634 München / DE
		02 11.05.1994 27.07.1994 ADMISSIBLE Behringwerke Aktiengesellschaft Emil-von-Behring-Strasse 76 35041 Marburg / DE Opponent's representative Lauppe, Hans Friedrich (DE) Behringwerke AG Postfach 11 40 D-35001 Marburg / DE
		03 11.05.1994 24.06.1994 ADMISSIBLE BOEHRINGER MANNHEIM GMBH Werk Penzberg Abt. GE-TB, Dr. Schreiner Postfach 1152 82372 Penzberg / DE
	Former [1994/27]
	Opponent(s)	01 11.05.1994 Xoma Corp. 2910 Seventh St. Berkeley, California 94710 / US Opponent's representative VOSSIUS & PARTNER P.O. Box 86 07 67 D-81634 München / DE
		02 11.05.1994 Behringwerke Aktiengesellschaft Emil-von-Behring-Strasse 76 35041 Marburg / DE Opponent's representative Lauppe, Hans Friedrich (DE) Behringwerke AG Postfach 11 40 D-35001 Marburg / DE
		03 11.05.1994 Boehringer Mannheim GmbH Patentabteilung Sandhofer Strasse 116 D-68298 Mannheim / DE
	24.05.1994	No. 02: Notification indicating deficiencies in the notice of opposition
	26.05.1994	No. 01: Notification indicating deficiencies in the notice of opposition
	26.05.1994	No. 03: Notification indicating deficiencies in the notice of opposition
	01.06.1994	No. 01: Reply to notification indicating deficiencies in the notice of opposition
	08.06.1994	No. 03: Reply to notification indicating deficiencies in the notice of opposition
	08.07.1994	No. 02: Reply to notification indicating deficiencies in the notice of opposition
	01.08.1994	Invitation to proprietor to file observations on the notice of opposition
	05.04.1995	Reply of patent proprietor to notice(s) of opposition
	12.11.1996	Date of oral proceedings
	26.11.1996	Despatch of a communication from the opposition division (Time limit: M04)
	26.11.1996	Despatch of minutes of oral proceedings
	23.01.1997	Reply to a communication from the opposition division
	24.04.1997	Despatch of interlocutory decision in opposition
	03.05.2001	Legal effect of interlocutory decision in opposition
	13.07.2001	Despatch of communication that the patent will be maintained as amended
	07.09.2001	Fee for printing new specification paid
Appeal following opposition	10.06.1997	Appeal received No. T0669/97
	04.09.1997	Statement of grounds filed
	03.05.2001	Result of appeal procedure: continuation of opposition procedure
	03.05.2001	Date of oral proceedings
	16.05.2001	Minutes of the oral proceedings despatched
Request for further processing for:	28.01.1993	Request for further processing filed
	29.01.1993	Full payment received (date of receipt of payment) Request granted
	12.02.1993	Decision despatched
Fees paid	Renewal fee
	18.09.1987	Renewal fee patent year 03
	14.09.1988	Renewal fee patent year 04
	11.09.1989	Renewal fee patent year 05
	21.09.1990	Renewal fee patent year 06
	09.09.1991	Renewal fee patent year 07
	28.09.1992	Renewal fee patent year 08
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited in	International search	EP0068763 [ ] (UNIV TEXAS [US]);
		EP0090898 [ ] (GENETIC SYSTEMS CORP [US]);
		WO8303971 [ ] (HARVARD COLLEGE [US]);
		WO8400382 [ ] (US HEALTH [US]);
		EP0105521 [ ] (TAKEDA CHEMICAL INDUSTRIES LTD [JP]);
		EP0120694 [ ] (CELLTECH LTD [GB]);
		EP0150126 [ ] (IMMUNEX CORP [US]);
		EP0125023 [ ]
		[A] - CHEMICAL ABSTRACTS, Volume 95, No. 4, 27 July 1981, Columbus, Ohio (US) V. RASO et al.: "Hybrid Antibodies with Dual Specificity for the Delivery of Ricin to Immunoglobulin-Bearing Target Cells", see page 363, Abstract 30711m, & Cancer Res. 1981, 41(6) 2073-8 (Eng.)
		[XP] - Nature, 314, No. 6010, April 1985 London (GB) SHUN-ICHI TAKEDA et al.: "Construction of Chimaeric Processed Immunoglobulin Genes Containing Mouse Variable and Juman Constant Region Sequences", pages 452-454, see the whole article
		[XP] - Nature 314, No. 6008, 21st March 1985 London (GB) M. NEUBERGER et al.: "A Hapten-Specific Chimaeric Ig E Antibody with Human Physiological Effector Function", pages 268-270, see the whole article
		[XP] - Nature 312, No. 5995, December 1984 London (GB) G. BOULIANNE et al.: "Production of Functional Chimaeric Mouse/Human Antibody", pages 643-646, see the whole article
		[XP] - Nature 312, No. 5995, December 1984 London (GB) M. NEUBERGER et al.: "Recombinant Antibodies Possessing Novel Effector Functions", pages 604-608, see the whole article

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.1.24; 35p